Voices of Healthcare · #20
Bobby Reddy, Jr.
Co-founder and CEO
Prenosis
Prenosis advanced FDA-authorized AI diagnostics for sepsis risk and pushed precision diagnostics into mainstream health recognition.
Bobby Reddy, Jr., PhD, co-founded Prenosis and serves as CEO. Prenosis builds AI-driven diagnostic tools that combine biological signals and clinical data, with a flagship focus on early sepsis risk assessment.
The company's Sepsis ImmunoScore work earned major invention recognition and a commercial path that includes large diagnostics distribution partnerships. That combination of regulatory progress and hospital deployment is still uncommon in clinical AI.
Prenosis is not currently a scored HIR review page.